Published in

Taylor and Francis Group, Leukemia & Lymphoma, 1(58), p. 64-69

DOI: 10.1080/10428194.2016.1187274

Links

Tools

Export citation

Search in Google Scholar

Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*

Journal article published in 2016 by Tara Baetz, Bingshu E. Chen ORCID, Stephen Couban, C. Tom Kouroukis, Rena Buckstein, John Kuruvilla, Kang Howson-Jan, David Szwajcer, Massimo Federico, Ralph M. Meyer, Marina S. Djurfeldt, Annette E. Hay ORCID, Lois Shepherd, Michael Crump
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO